Danhong injection enhances the therapeutic efficacy of mesenchymal stem cells in myocardial infarction by promoting angiogenesis
Stem cell-based therapies have the potential to dramatically transform the treatment and prognosis of myocardial infarction (MI), and mesenchymal stem cells (MSCs) have been suggested as a promising cell population to ameliorate the heart remodeling in post-MI. However, poor implantation and surviva...
Päätekijät: | Chen, J, Wei, J, Huang, Y, Ma, Y, Ni, J, Li, M, Zhu, Y, Gao, X, Fan, G |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Frontiers Research Foundation
2018
|
Samankaltaisia teoksia
-
Efficacy and safety of Danhong injection for treating myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
Tekijä: Shiyi Yang, et al.
Julkaistu: (2024-06-01) -
Promoting effect of Shenmai injection on myocardial angiogenesis in rat models with myocardial infarction
Tekijä: ZENG Yu-ling, LI Shi-ge, ZHAN De-jin
Julkaistu: (2021-11-01) -
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
Tekijä: Teng Ma, et al.
Julkaistu: (2018-01-01) -
Regulation of angiogenesis in experimental myocardial infarction zone by application of multipotent mesenchymal stem cells
Tekijä: V. Yu. Mikhailichenko, et al.
Julkaistu: (2015-04-01) -
Identification and Validation of Diagnostic Model Based on Angiogenesis- and Epithelial Mesenchymal Transition-Related Genes in Myocardial Infarction
Tekijä: Li Z, et al.
Julkaistu: (2024-07-01)